Egret Therapeutics completes oversubscribed pre-A financing round
/PRNewswire/ -- Egret Therapeutics, a clinical-stage biotherapeutics company focused on the treatment of neurological diseases, announced today the completion...
Jaemoon Lee Daniel Chai Christopher Jackson Fascinate Therapeutics Inc Chairperson Of Neurosurgery At Stanford Medical Center Egret Therapeutics
Source: prnewswire.com